Acorah Software Products - Accounts Production 15.0.600 false true 31 March 2023 24 February 2022 false true No description of principal activity 1 April 2023 31 March 2024 31 March 2024 13939008 Mr Mohammad Ansari iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 13939008 2023-03-31 13939008 2024-03-31 13939008 2023-04-01 2024-03-31 13939008 frs-core:CurrentFinancialInstruments 2024-03-31 13939008 frs-bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 13939008 frs-bus:FilletedAccounts 2023-04-01 2024-03-31 13939008 frs-bus:Micro-entities 2023-04-01 2024-03-31 13939008 frs-bus:AuditExempt-NoAccountantsReport 2023-04-01 2024-03-31 13939008 frs-bus:Director1 2023-04-01 2024-03-31 13939008 2022-02-23 13939008 2023-03-31 13939008 2022-02-24 2023-03-31 13939008 frs-core:CurrentFinancialInstruments 2023-03-31
Registered number: 13939008
MYA Pharma Limited
Financial Statements
For The Year Ended 31 March 2024
Balance Sheet
Registered number: 13939008
31 March 2024 31 March 2023
£ £
Fixed assets 286 362
Current assets 21,367 30,584
Creditors: Amounts Falling Due Within One Year (2,209 ) (10,199 )
NET CURRENT ASSETS 19,158 20,385
TOTAL ASSETS LESS CURRENT LIABILITIES 19,444 20,747
Accruals and deferred income - (450 )
NET ASSETS 19,444 20,297
CAPITAL AND RESERVES 19,444 20,297

Notes

1. General Information
MYA Pharma Limited is a private company, limited by shares, incorporated in England & Wales, registered number 13939008 . The registered office is 87 Ginnell Farm Avenue, Rochdale, Lancashire, OL16 4GF.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2023: 1)
1 1
For the year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
On behalf of the board
Mr Mohammad Ansari
Director
15/08/2024